AI for Health Summit 2022

🇬🇧 What is the impact of digital health partnerships on the pharma market access strategy?

Nov 16, 2022 | 2:30 PM CET - 3:00 PM CET

Description

- Early access to novel and effective health technologies is critical to improve patient outcomes and healthcare systems sustainability. However, across Europe delays in access and availability of novel therapies not only harm patient and health system sustainability, but also create health inequities. - Digital health and health data hold great promise to enable innovative solutions to unlock access and improve outcomes by facilitating personalized medicines, integrated care delivery, and generation of data and evidence to support better healthcare choice for patient, health system and society.

Presented By

Siddhesh Gandhi

Novartis BIOME Paris Lead

Tuan-Duc Pham

Patient Access Director Europe Region

Teaser Sessions

5:20 pm CET - 6:20 pm CET

Startups Masterclass Stage

🇬🇧🇫🇷 Investors Tour - Startups x Investors speed meetings

⬇️ Are you a startup using AI, data in health? Go & meet +10 investors for 5mn speed meeting to present your startup! Prepare your deck and pitch up to 11 of the...

Animated by Christophe FOURLEIGNIE DUC

Chief Operating Officer

10:25 am CET - 10:40 am CET

Startups Masterclass Stage

🇬🇧 New AI solutions for improved cancer diagnosis and optimized treatment

The latest advances in AI revolutionized the field of histopathology. Tribun Health, a computational pathology pioneer, empowers pathology labs and pharma sponsors with...

AI & Computer Vision Director

12:00 pm CET - 12:10 pm CET

Startups Masterclass Stage

🇫🇷 Construire le futur de la psychiatrie de précision dans le parcours de soin de pathologies...

Current approaches to the detection, diagnosis and monitoring of psychiatric disorders rely heavily on the experience of the psychiatrist and on physician-patient...

Yannick Trescos

ResilEyes Therapeutics

CEO & Co-founder

9:55 am CET - 10:05 am CET

🇬🇧 Real World Evidence to Inform Health Decisions : Data and Methodological Considerations for...

VP Analytics And Insight RWE